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Cell metabolite analysis is of great interest to analytical chemists and physiologists, with some meta-
bolites having been identiﬁed as important indicators of major diseases such as cancer. A high-
throughput and sensitive method for drug metabolite analysis will largely promote the drug discovery
industry. The basic barrier of metabolite analysis comes from the interference of complex components in
cell biological system and low abundance of target substances. As a powerful tool in biosample analysis,
microﬂuidic chip enhances the sensitivity and throughput by integrating multiple functional units into
one chip. In this review, we discussed three critical steps of establishing functional microﬂuidic platform
for cellular metabolism study. Cell in vitro culture model, on chip sample pretreatment, and microchip
combined detectors were described in details and demonstrated by works in ﬁve years. And a brief
summary was given to discuss the advantages as well as challenges of applying microchip method in cell
metabolite and biosample analysis.
& 2015 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved. This is an
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Studying cellular metabolites under various environmental
stimuli such as drug conditioned culture and multiple cell types
interaction, can provide meaningful results for drug discovery andon and hosting by Elsevier B.V. All
University.
Lin).a better understanding of important biological progress, especially
those involved in the occurrence of major deceases [1,2] like
cancer. Diagnosing methods deﬁning metabolic species as
indicators for carcinoma have been well established and applied in
hospital. Also, rather than focusing on one single metabolite, the
combinatorial study of several or even all metabolites in a certain
time section, which is termed metabolomics, is increasingly at-
tracting the interest of scientists [3,4]. Following the popularity of
genomics and proteomics, metabolomics may provide a newrights reserved. This is an open access article under the CC BY-NC-ND license
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are several challenges remaining in metabolites proﬁling. Trace
amount metabolites secreted from cells often exist in a complex
mixture of various components such as proteins, nucleic acids and
other biomolecules. The detection of a metabolite requires efﬁ-
cient separation and preconcentration scheme, and a highly sen-
sitive detector. Besides, time consumption, chemical reagents and
cost have to be balanced to achieve practical usability.
In the industry of drug development, analytical methods for
compound metabolic pathway probing in a manner of high
throughput, rapidness and great sensitivity have always been in
avid demand, given the decades of time, billions of money and
intensive labor working spent in getting one drug registered in
USFDA. Actually, among several different screening steps con-
cerning compound structure stability and bioactivity in drug dis-
covery, clinical trial causes the largest expense. In the ﬁnal step of
clinical trial, most candidate compounds can be excluded by ad-
verse effects or low efﬁcacy [5,6], thus giving a dead end to all the
former testings and relevant investment. And currently, clinical
trial cannot be replaced by cell culture or animal experiment,
because of the uniqueness and complexity of human body. One
solution to reduce the time span and cost is to reconstruct a
comparable human body in vitro, at least at the organ level, which
is the basic functional unit in drug absorption, distribution, me-
tabolism and excretion (ADME).
Owing to the development of microfabrication technique, the
design and miniaturization of ﬂow channels can be easily and
cheaply completed in laboratory, which enables the wide use of
microﬂuidics. Microﬂuidics offers an alternative method to con-
ventional bench top analytical process and exhibits surprising
advantages. According to scaling laws, the decrease of reaction
volume adversely affects the mass/heat transfer, which meansFig. 1. Microﬂuidic device for celluenhancing the reactants exchanging by increasing the surface–
volume ratio and shortening the diffusion distance. Therefore,
chemical reactions can be more rapidly ﬁnished in a microﬂuidic
reactor. In addition, the perfect matching between microﬂuidic
channel dimension and cell size makes it a powerful tool for cell
handling and culture, and applicable to researches such as cell
positioning, sorting and circulating tumor cell (CTC) capture for
cancer diagnosis. The precise control of cell culture micro-
environment can be harnessed to mimic in vivo status. Also, the
miniaturization largely reduces the reagent and sample con-
sumption, and enables further integration of different functional
modes into one chip. This integration of sample introduction or
generation, pretreatment, and detection in a portable microchip is
highly preferred in the analysis of analytes with low amount, to
evade unwanted loss during off-line operation. The concept of lab
on a chip (LOC) or micro-total analysis system (μTAS) was pro-
posed to realize above goals, and has been developed with con-
siderable complexity of integration for high-throughput, parallel
and fully automated screening.
Therefore, microﬂuidic device is an ideal candidate in proﬁling
cellular metabolites [7–9] and drug screening [10–12] with the
ability to cover cell culture, metabolite generation, separation and
preconcentration as well as detection on one chip with the assis-
tance from extra detectors like MS and ﬂuorescence microscopy. In
this review, we will go through works concerning critical aspects
about application of microﬂuidic device in cellular metabolites
analysis in recent years. As mentioned above, on-chip analysis of
metabolite can be roughly divided into three steps: cell culture
model establishment and metabolites generation, sample pre-
treatment and detection (Fig. 1)[13]. Accordingly, our review will
have three main sections to demonstrate the corresponding issues.lar metabolism analysis [13].
Fig. 2. Schematics of building 3D cell culture environment. (A) Fabrication of alginate microwell array by electrodeposition [25]; (B) Fabrication of microcollagen array by
PDMS templet and gelation [26].
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The ﬁrst step towards developing microﬂuidic platform of
proﬁling cellular metabolites is to establish a similar cell culture
environment on chip compared to in vivo condition [14,15]. As we
all know, cells are basic building blocks constituting our body.
However, in our body, the higher hierarchy structures can be much
more complicated. Cells in vivo exist in a complex microenviron-
ment consisting of various soluble cellular factors and insoluble
extracellular matrix (ECM). These components regulate cell
behaviors such as migration, mitosis and apoptosis by ligand–re-
ceptor interaction, phosphorylation, opening up the downstream
signal pathway as well as affecting transcription factors. The gra-
dient of cytokines and ECM compose the chemical microenviron-
ment. Besides, cell–cell interaction within same or different cell
types is another essential part of microenvironment. Cell–cell in-
teraction can be regulated by secreting cellular factors or direct
contact, and abnormal cell–cell interaction is an important cause
of critical diseases like autoimmunity and cancer metastasis. The
last component which can be easily ignored is the mechanical
microenvironment. Cells in different tissues and organs may face
distinct mechanical forces. Red blood cell (RBC) and leukocyte
should endure the large shear forces by blood ﬂow, and epithelium
cells on the interfaces of alveolus-capillary can be stretched by the
inhalation and expiration during breath. Huh et al. [16] developed
a polydimethylsiloxane (PDMS) based in vitro lung model with
porous ﬁlm as alveolus interfaces to accommodate epithelial and
endothelial cells on opposite site, and mimicked the breathing
stretch by adding two pressure tuning side channels. When va-
cuum was applied to side channels, the elastic PDMS walls gen-
erated deformation and gave pulling force on the cell culture ﬁlm,
thus resulting in the stretch similar to an actual lung. The model
was applied to investigate the cell toxicity of nanoparticles. Also,
other microﬂiudic devices have been developed to systematically
study the effects of mechanical microenvironments, such as ﬂuidic
shear stress [17] and surface strain [18,19], with tunable magni-
tude of forces upon monolayer of endothelial cells. Results re-
vealed that cell orientation and formation of cell skeleton were
signiﬁcantly inﬂuenced by mechanical stress. Actually, 2D en-
dothelium is especially suitable for the investigation of membrane
stress due to its tendency to form integrated monolayer and easy
combination with ﬂuorescence imaging and other optical ob-
servation methods. With the assistance from pressure-mediated
microvalve and precisely controlled microﬂuidic system, regionally
selective and magnitude determined mechanical stimuli are easily
achieved. Several strategies are provided to realize the construc-
tion in vitro culture model after the basic elements of which were
reviewed.
2.1. 3D cell culture
Conventional dish culture of cell gives 2D monolayer structure,
where cells adapt to show ﬂat morphology. While in vivo, cells are
more likely “ﬂoating” in the ECM, supported by the various
structural proteins like collagen, laminin and ﬁbronectin, thus
presenting more extensive shapes. The differences of 3D and 2D
culture are not limited in the morphology. Evidence shows shapes
under 2D culture, cells lose functionality [20], go dedifferentiated
[21] and exhibit different expression levels of several important
genes [22]. In contrary, 3D culture helps cells maintain phenotypes
even after weeks of in vitro culture [23,24]. One scheme to im-
plement 3D culture is to accommodate cells in biocompatible
hydrogen such as agarose, alginate, matrigel and collagen, sup-
plemented with ECM components for a better cell attachment.
Ozawa et al. [25] developed an alginate 3D model for embryonic
stem cells and HepG2 culture based on electrodeposition ofalginate gel (Fig. 2A). Indium tin oxide (ITO) electrode is selectively
patterned on substrate surface, upon which the electrolysis of
water produces Hþ , dissolving the CaCO3 particles in alginate so-
lution, thus forming microwells of alginate gel. Embryonic bodies
and HepG2 spheroids were formed in 3D culture, which demon-
strated the validity of culture platform. Guan et al. [26] developed
a facile and rapid method to generate a large microcollagen array
for long-term cell culture and screening of drug resistance het-
erogeneity (Fig. 2B). Cell culture chamber was fabricated by ful-
ﬁlling PDMS microwells with cell collagen suspension, and se-
quentially gelatinized to form 3D culture gel. Long-term culture
was maintained as long as 30 days at single cell level, with the
ability to retrieve any cell of interest for further examination.
Collagen based 3D microtissue culture models for cell viability
assessment [27] or immunoassay of cytotoxicity [28] under drug
stimulation were also reported, which were compatible to mi-
croplate reader. This platform provides a high throughput and
quantitative method for drug screening and better prediction of
drug efﬁcacy at the tissue level.
Droplet technique in microﬂuidic has always been highlighted
especially in the ﬁeld of biosample analysis, due to its precise
control of deﬁned volume, minimized reagent consumption and
prevention in cross contamination. Microﬂuidic droplet is broadly
applied in constructing 3D culture models with clever art of hy-
drogel gelation. In a recent work from Utech et al. [29], calcium
ethylene diamine tetraacetic acid (Ca-EDTA) chelate was mixed
with alginate solution as the dispersed phase. After the alginate
droplet was made at nozzle by ﬂow focusing, Hþ in oil phase
gradually diffused into the microdroplet and released Ca2þ which
further solidiﬁed the alginate. Besides, the gelation process can
also be conveniently controlled by sequential adjustment of the
temperature for agarose or matrigel based droplet, or selective
exposure to ultraviolet (UV) for PEG hydrogel. Microﬂuidic droplet
technique realizes monodispersed, and highly uniformed gel
droplet for cell encapsulation at the single cell level, providing a
platform for high throughout cell culture and screening.
Combined with microarray presentation, parallel experiments
can be performed in multi-parameters drug screening. Du et al.
[30] reported a droplet based microﬂuidic system for drug com-
bination screening (Fig. 3). In this system, droplet is conﬁned in
the array of microwells which are covered by a layer of oil to
isolate each droplet. Sequential operations such as cell seeding,
drug addition and stimulation, and ﬂuorescence probing can be
completed by a tapered capillary. The system was validated by
exploring the effects of drug combination based on cell viability
testing.
2.2. Cell co-culture
Any tissue or organ with certain function in human body is
composed of large cell populations and multiple cell types. Inter-
actions between multiple cell types constitute a stable and func-
tional organism, while the absence of proper intercellular inter-
action may severely alter the behavior of cells. It has been reported
that complex interaction between cancer and endothelial cells
mediated by cell factors such as vascular endothelial growth factor
(VEGF) and transforming growth factor-β (TGF-β) would increase
the drug resistance of tumor and induce angiogenesis [31,32].
Therefore, in the aspect of drug metabolite proﬁling and efﬁciency
testing, data from single cell type experiment can be rather lim-
ited. Under this circumstance, cell co-culture model is being paid
intensive attention to improve the traditional screening platform.
In a work of our group, a CaSki cells and human umbilical vein
endothelial cells (HUVECs) co-culture model under different levels
of oxygen (5% and 15%) was developed to study the cell-cell
communication in cervical cancer development (Fig. 4) [33].
Fig. 3. Cell culture droplet array for drug combination screening. (A) Photo of device set up; (B), (C) Fluorescence images of cell culture array with A549 cells [30].
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acid and chromogenic system online, and other metabolism re-
lated species such as reactive oxygen species (ROS) were also
studied. Another work by Mao et al. [13] suggested a cell co-cul-
ture model to emulate the epinephrine communication between
293 and L-02 cells by connecting two cell culture chambers in the
dynamic on-chip culture. When acetylcholine is infused into the
culture system, 293 cells on the upstream are stimulated and thus
produce epinephrine, which will affect L-02 cells on the down-
stream chamber and enhance its glucose secretion. The ﬁnal me-
tabolite, glucose, as well as signaling molecule, epinephrine, was
successfully detected by electrospray ionization-quadrupole-time
of ﬂight-mass spectrometry (ESI-Q-TOF-MS). This work provides a
useful platform to study the inﬂuence of cell-cell communication
upon metabolic pathway.
2.3. Organ on chip
Organ is the basic functional unit in drug metabolism, and the
ADME process concerning drug efﬁciency is actually carried out at
the organ level. To have a systematic view of drug metabolic
pathway, one has to construct a model more closely emulating
organ functions rather than a single or a few cell types co-culture,
which is termed “organ on chip” or even “body on chip” [34–36].
Among all kinds of organs, liver is the most frequently investigated
one because of its high metabolic activity in drug metabolism.
Zhang et al. [37] reported an in vitro liver model with the func-
tionality of metabolizing the prodrug capecitabine to produce ananti-cancer intermediate (Fig. 5A). HepG2 was cultured to emulate
the liver function, while MCF-7 cell was a representative of tumor.
Prodrug and its intermediate were detected by on-line solid phase
extraction (SPE) and mass spectrometry (MS) with a limit of de-
tection (LOD) of 10 nM. Imura et al. [38] developed a more com-
plicated biosystem to assess the drug absorption of intestine and
metabolism of liver as well as its bioacitivity on target cells (Fig.
5B). Caco-2, HepG2 and MCF-7 were cultured on chip to represent
the modules of intestine, liver and tumor, respectively. The plat-
form provides an efﬁcient assessment to the oral administrated
medicine.
Organ on chip or body on chip is a potential tool which may
greatly promote the clinical treatment, especially point-of-care
diagnosis and personal specialized therapy. However, one chal-
lenge remaining to be solved is how to accommodate dozens of
cell populations and sub-cell populations into an in vitro model
with proper proportion and position [35]. For example, there are
entities of hepatic cells, vascular endothelial cells and preicytes,
and other immune related lymphocytes in liver. The culture
technique for some cell types is still immature and unsatisfactory.
But hopefully, with the assistance of newly emerging methods
such as bioprinting [39,40], one day we may construct an “organ”
with more complex architectures and more power of control.
3. Sample pretreatment on chip
After the construction of biomodel on chip and drug stimula-
tion, the following procedure is to detect drug metabolites with
Fig. 4. Cell co-culture microﬂuidic system under different oxygen gradients. (A) Oxygen induced cell-cell communication; (B) Illustration of microchip structure;
(C) Microvalve constituted by micropillars; (D) Two-layer cell co-culture device under low oxygen condition; (E) Schematics of cell secretion detection [33].
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treatment has to be carried out on microchip in advance, because
the complex compositions among culture medium may severely
inhibit the ionization efﬁciency and interfere the detection of a
target molecule of low abundance or trace amount. Considering
the limited volume of analysis system, pretreatment, roughly di-
vided as preconcentration and separation, must have low sample
consumption. And on-line pretreatment is preferred to increase
the integration and automation of the platform, while avoiding
unnecessary sample loss occurred in off-line method.
3.1. Preconcentration methods
Our group has published a series of works employing micro-
SPE columns integrated to cell culture chip for establishment of
drug cellular testing platform [41], study of cell-cell communica-
tion [13] and drug metabolism [42,43]. Commercialized SPE beads
were infused and immobilized in a microchamber with shrinking
ends to receive the upstream cell culture medium with drug me-
tabolites. Analytes were captured and thus desalted by the micro-
extraction process. When elution buffer was added, the dissolved
metabolite was online analyzed by ESI-MS. Highly parallel ex-
periments can be performed on the same chip by arranging mul-
tiple cell cultures and SPE channels to investigate the effects of
different concentrations of a drug.
Another method developed by our group realized the extrac-
tion of cell metabolites from culture medium via microdialysis
(Fig. 6A) [44]. A homemade microdialysis hollow ﬁber was im-
mersed into cell culture medium, and as dialysate ﬂowed into the
ﬁber, glucose from culture media diffused through dialysis inter-
face. The other end of the ﬁber came to paper spray ionization for
MS detection. With the continuously ﬂowing dialysate and gen-
erating droplets, on-line monitoring at glucose level in cell culture
medium was achieved with the shortest time interval of 1.5 s. This
work demonstrated a potential platform with label free MS de-
tection for the monitoring of cellular culture system.3.2. Microseparation
Chromatography is a highly efﬁcient method for the separation
and identiﬁcation of analytes among complex matrix. There are
standards of drug metabolite analysis based on the mature gas
chromatography-mass spectrometry (GC-MS) or liquid chromato-
graphy-mass spectrometry (LC-MS) techniques. For microsepara-
tion, microchip electrophoresis (MCE) assumes the most success-
ful miniaturization of chromatography, including operations of
sample introduction, derivatization, separation and detection in a
conﬁned small area of few square centimeters. MCE is applicable
to analysis of genes, amino acids, proteins and even single cells.
The principle of MCE is based on the employment of electro-
osmotic ﬂow, the rate of which can be controlled by modifying
inner surface or adjusting buffer composition, thus realizing the
separation of substances with different motilities. Frequently used
detecting methods coupled to CE separation include UV absor-
bance, ﬂuorescence and electrochemical sensor. Normally, absor-
bance test requires an enough high concentration of analyte, or a
large molar extinction coefﬁcient, which is often inapplicable to
cell metabolite analysis. Although ﬂuorescence and electro-
chemical method are frequently used in metabolite detection, each
of them has their own advantages. Fluorescence provides sig-
niﬁcantly better sensitivity even at the single molecule level, but
speciﬁc probes are necessary to label the targets. For electroactive
substances, electrochemical method is label-free without re-
quirement of derivatization or extra bulky device which increases
the portability of the device. For instance, electrochemical method
is an ideal tool for saccharides analysis, because there is no func-
tional group for the addition of ﬂuorophore, neither do sacchar-
ides have large molar extinction coefﬁcient. Our group reported a
microchip-CE method for assay of multiplex cell metabolism re-
lated proteins (Fig. 6B) [45]. Aptamers for recognition of platelet-
derived growth factor-BB (PDGF-BB), VEGF165 and thrombin were
designed to have different lengths, which modulate the electro-
phoretic mobility of respective proteins by speciﬁc bonding. The
Fig. 5. Schematics of constructing on chip organ model. (A) Multiple parallel channels for cell culture, metabolism and metabolite extraction in an in vitro liver model [37];
(B) Assessment of drug absorption, metabolism and effect on tumor by intestine-liver-cancer model on chip [38].
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reduces the matrix interference. There are other works concerning
the application of MCE in metabolites probing with combination of
electrochemical [46] or ESI-MS detection [47]. The sensitivity and
quantitative ability of CE can be further strengthened via mod-
iﬁcation of sample introduction manner such as inkjet direct
sampling. (Fig. 7) [48].
Another miniaturization by integrating LC column into a mi-
crochip combined with MS detection also demonstrates a great
capacity for metabolite analysis, which can be termed microchip-
LC-MS. Compared with conventional LC, microchip-LC separation
is much faster and costs lower sample consumption, thus largely
increasing the throughput. Sainiemi et al. [49] reported a silicon LC
system on chip with micropillars functionalized with SiO2 or C18
coating as a basic separation unit. Separation can be completed in
5 min with good sensitivity of MS or ﬂuorescence detection. Also,
microchip based liquid chromatography system has been well
established and commercialized by several companies [50].
4. Detection
As mentioned above, commonly used detectors for microﬂui-
dic cellular analysis platform include ﬂuorescence microscopy,electrochemical and MS methods. High sensitivity, good speciﬁ-
city, low cost and short time period are preferred characteristics
for a detector, especially in microanalysis of complex system (for a
detailed and comprehensive discussion about detectors suitable
for biospecies detection, readers can refer to previously published
review [51]). But sometimes, the size of detector may determine
the usability of a platform, if portability is in high favor. For ex-
ample, electrochemical method can be miniaturized to a micro-
electrode, which can be selectively patterned in microﬂuidic
channels and realize region conﬁned detection. Several works re-
ported a patch type metabolite monitor with an array of micro-
electrodes on needle tip for non-enzymatic detection of interstitial
glucose level [52] or lactate level [53]. Although in animal models,
the method may be short-lived compared with in vitro experi-
ments, it is still a potential complement to disease therapy like
diabetes. Besides, the integration of features in nano scale may
greatly increase the detection performance by exhibiting large
contact area and thus gaining high probability in capturing target
molecular or target cells [54]. But in general, MS is the most
powerful tool in metabolite analysis, due to the abundant struc-
tural information given in a MS spectrogram. With the ability to
complete simultaneous detection of multiple analytes by different
charge-to-mass ratios, the analytical capacity of MS covers
Fig. 6. Cell metabolism related sample preconcentration and microseparation methods. (A) Microdialysis to extract glucose for paper spray ionization from cell culture
medium [44]; (B) Cell metabolism proteins assay based on tunable aptamer and microchip-CE [45].
Fig. 7. Drop-by-drop sample introduction by ink jet for CE method. (A) Illustration of ink jet sample introduction to CE; (B) NBD-F derivatization of amino acids by drop-by-
drop sample introduction [48].
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proteins and nucleic acids. Recently, the rapid development of high
resolution MS pushes LOD to fmol. Besides, fast speed of over one
hundred times full-spectrum scanning per second is compatible
and applicable to probe biochemical reactions completed in mil-
liseconds inside cell. As for drug metabolite identiﬁcation, the
composing elements and structural information of drug com-
pound can be easily obtained by multiple determining methods
[55,56]. In microchip-MS combination, one critical issue is the
interfaces between microchip ﬂow and MS ionization region.
Therefore, ionization methods such as ESI, paper spray and matrixassisted laser deposition ionization (MALDI) are carefully reviewed
to address above problem.
4.1. ESI
ESI method enables direct ionization of target molecule in li-
quid buffer, and is often conveniently combined with LC separa-
tion. For microchip-MS method, the ﬂow rate of microﬂuidic dy-
namic culture system is comparable to nanoﬂow ESI, and via ex-
ternal connecting silicon fused capillary, sample can be directly
introduced from microchip into ESI with on-line SPE channels (Fig.
Fig. 8. Microchip-MS interfaces with multichannel set up for concentration de-
pended screening. (A) Combination of microchip to ESI-MS detection [41];
(B) Combination of microchip to paper spray MS detection [64].
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electrospray composed of PDMS [57] or glass material [58,59]. The
integration of electrospray emitter onto microchip gives better
combination to other on chip functional blocks such as MCE, and
further increases the sensitivity as well as throughput by densely
arrangement of multiple nozzles. Mao et al. [60] introduced a
multi-nozzle emitter array consisting of 96 10-nozzle emitters in a
circular array on a silicon chip. The platform provided advantages
such as no cross-contamination and highly parallel experiments.
4.2. Paper spray
Paper spray is a facile, cheap and highly efﬁcient ionization
method for qualitative and quantitative MS analysis of complex
samples such as dried blood [61], fruit juice [62] and body meta-
bolites [63]. Paper spray presents great matrix tolerance with
simple sample introducing fashion. Buffer with analyte is directly
dripped onto paper surface, and as the paper gets wet, the analyte
driven by electric ﬁeld gradually moves to the tip and spray. In the
whole process, electro-inert substances remain still, thus realizing
a separation of target molecule from matrix. Our group has de-
veloped a multichannel microchip device with a movable capillary
to sequentially aspirate different samples in different channels
(Fig. 8B) [64]. The sample was transported in droplet and sepa-
rated by air plug until it fell onto the paper surface and sprayed.
The process was in full automation and controlled by the com-
puter, which made the device a potential platform for high
throughput screening of biomolecular interaction or cellmetabolite under drug stimulation.
4.3. Maldi
MALDI is well tolerant to salt and non-volatile components of
buffer system. But in the region of molecular weight under 500 Da,
fragments from matrix composition signiﬁcantly raise up the
background noises which are unfavorable to small molecule ana-
lysis [65]. Due to the vacuum condition required by MALDI, the on-
line coupling of microchip to MALDI is rather difﬁcult. Instead, off-
line methods of depositing samples onto MALDI target plate after
microchip operation are well developed. A series of works about
constructing a micro-bioreactor by covalently immobilizing tryp-
sin onto glass ﬁber [66] or microchannel inner surface have been
reported [67,68]. Proteins such as hemoglobin and cytochrome c
were digested by trypsin and further collected for deposition to
MALDI target and MS detection. With the assistance of micro-
ﬂuidic reactor, time period for proteolysis can be reduced to less
than 5 s. The platform demonstrated great capacity for identiﬁ-
cation and analysis of complex protein samples. Mikkonen et al.
[69] reported an open microchannel for charged sample pre-
concentration and direct usage as MALDI target plate. Peptides of
cytochrome c digested by trypsin were preconcentrated at differ-
ent positions of microchannel, and determined by pH gradient of
water electrolysis. MALDI-MS detection was carried out by de-
positing matrix and enhancing crystallization into channel. This
work provides a direct combination of microchip-MS method, thus
evading the possible cross contamination and sample loss.5. Conclusions and perspectives
Construction of cell in vitro model, on chip sample pretreat-
ment and detection are three critical parts concerning a successful
integrated microchip method for cellular metabolism study. Since
the appearance of microﬂuidic chip, lab on chip method has al-
ways been paid intensive attention, especially in the ﬁeld of bio-
sample analysis. Microﬂuidic platform has been proved an ideal
candidate for cell metabolism analysis with at least four
advantages:
i. The micro scale of channel geometry provides precise control of
cell culture microenvironment and delicate cell manipulation
scheme;
ii. On-line separation and preconcentration methods avoid the
loss of sample and increase the detection sensitivity;
iii. Microchip interfaces are compatible with various detectors
such as MS, ﬂuorescence microscopy and electrochemical sen-
sor with little or without necessary further modiﬁcation, which
strengthens the capability of metabolite detection;
iv. With integrated functions and multiple parallel channels, mi-
croﬂuidic platform allows operation in full automation with
high throughput.
However, there are still challenges before a wider application of
microﬂuidic platform come to drug screening and cellular events
study. How can we establish a proper cell culture model with
perfect simulation of tissue or organ functions meanwhile allow-
ing transparent and thorough investigation of the system? How
will the separation and detection method be developed to probe
components inside cells of less content but with important bio-
logical signiﬁcance? Addressing these questions may require hard
work and wisdom of generations. But actually, microﬂuidic plat-
form has already revolutionized the way of bioanalysis and life
analysis.
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